Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Suppression of Superficial Microglial Activation by Spinal Cord Stimulation Attenuates Neuropathic Pain Following Sciatic Nerve Injury in Rats.

Shinoda M, Fujita S, Sugawara S, Asano S, Koyama R, Fujiwara S, Soma K, Tamagawa T, Matsui T, Ikutame D, Ando M, Osada A, Kimura Y, Kobayashi K, Yamamoto T, Kusama-Eguchi K, Kobayashi M, Hayashi Y, Iwata K.

Int J Mol Sci. 2020 Mar 30;21(7). pii: E2390. doi: 10.3390/ijms21072390.

2.

Involvement of Satellite Cell Activation via Nitric Oxide Signaling in Ectopic Orofacial Hypersensitivity.

Lee J, Ohara K, Shinoda M, Hayashi Y, Kubo A, Sugawara S, Asano S, Soma K, Kanno K, Ando M, Koyama R, Kimura Y, Sakanashi K, Iinuma T, Iwata K.

Int J Mol Sci. 2020 Feb 13;21(4). pii: E1252. doi: 10.3390/ijms21041252.

3.

Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study.

Kato M, Yamada T, Kataoka S, Arai Y, Miura K, Ochi Y, Ihara H, Koyama R, Sasaki S, Takahashi K.

Respir Res. 2019 Dec 18;20(1):287. doi: 10.1186/s12931-019-1247-z.

4.

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer.

Nakagawa K, Hida T, Nokihara H, Morise M, Azuma K, Kim YH, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Hotta K, Watanabe S, Goto K, Satouchi M, Kozuki T, Koyama R, Mitsudomi T, Yamamoto N, Asakawa T, Hayashi M, Hasegawa W, Tamura T.

Lung Cancer. 2020 Jan;139:195-199. doi: 10.1016/j.lungcan.2019.11.025. Epub 2019 Nov 28.

PMID:
31812890
5.

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.

Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, Chiu CH, Park K, Novello S, Nadal E, Imamura F, Yoh K, Shih JY, Au KH, Moro-Sibilot D, Enatsu S, Zimmermann A, Frimodt-Moller B, Visseren-Grul C, Reck M; RELAY Study Investigators.

Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4.

PMID:
31591063
6.

Age is an independent predictor in pathological diagnosis of sarcoidosis: a retrospective analysis of diagnosis by endobronchial ultrasound-guided transbronchial needle aspiration.

Kuwasaki E, Nagaoka T, Ihara H, Tsutsumi T, Nakamura A, Yoshikawa H, Yoshida T, Watanabe J, Ichikawa M, Koyama R, Shimada N, Takahashi K.

J Thorac Dis. 2019 May;11(5):2175-2180. doi: 10.21037/jtd.2019.01.94.

7.
8.

Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.

Nakamura K, Kato M, Shukuya T, Mori K, Sekimoto Y, Ihara H, Kanemaru R, Ko R, Shibayama R, Tajima K, Koyama R, Shimada N, Nagashima O, Takahashi F, Sasaki S, Takahashi K.

BMC Cancer. 2017 May 2;17(1):302. doi: 10.1186/s12885-017-3285-6.

9.

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.

Tambo Y, Hosomi Y, Sakai H, Nogami N, Atagi S, Sasaki Y, Kato T, Takahashi T, Seto T, Maemondo M, Nokihara H, Koyama R, Nakagawa K, Kawaguchi T, Okamura Y, Nakamura O, Nishio M, Tamura T.

Invest New Drugs. 2017 Apr;35(2):217-226. doi: 10.1007/s10637-017-0435-2. Epub 2017 Jan 30.

PMID:
28138828
10.

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators.

N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6.

11.

DNase γ, DNase I and caspase-activated DNase cooperate to degrade dead cells.

Koyama R, Arai T, Kijima M, Sato S, Miura S, Yuasa M, Kitamura D, Mizuta R.

Genes Cells. 2016 Nov;21(11):1150-1163. doi: 10.1111/gtc.12433. Epub 2016 Sep 22.

12.

Acrolein scavengers, cysteamine and N-benzylhydroxylamine, reduces the mouse liver damage after acetaminophen overdose.

Koyama R, Mizuta R.

J Vet Med Sci. 2017 Jan 10;78(12):1903-1905. doi: 10.1292/jvms.16-0325. Epub 2016 Sep 5.

13.

Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma.

Kanemaru R, Morio Y, Takekawa H, Jo H, Kasuga F, Koyama R, Shiota S, Nagaoka T, Takahashi K.

Respir Investig. 2016 Sep;54(5):372-5. doi: 10.1016/j.resinv.2016.04.001. Epub 2016 Jun 6. No abstract available.

PMID:
27566387
14.

Bevacizumab-induced chronic interstitial pneumonia during maintenance therapy in non-small cell lung cancer.

Sekimoto Y, Kato M, Shukuya T, Koyama R, Nagaoka T, Takahashi K.

Respirol Case Rep. 2016 Mar 31;4(2):e00151. doi: 10.1002/rcr2.151. eCollection 2016 Apr. Erratum in: Respirol Case Rep. 2016 Jul;4(4):e00166.

15.

Cerebral infarction in advanced non-small cell lung cancer: a case control study.

Kato M, Shukuya T, Mori K, Kanemaru R, Honma Y, Nanjo Y, Muraki K, Shibayama R, Koyama R, Shimada N, Takahashi F, Takahashi K.

BMC Cancer. 2016 Mar 10;16:203. doi: 10.1186/s12885-016-2233-1.

16.

Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.

Shukuya T, Ko R, Mori K, Kato M, Yagishita S, Kanemaru R, Honma Y, Shibayama R, Koyama R, Shimada N, Takahashi K.

Cancer Chemother Pharmacol. 2015 Oct;76(4):771-6. doi: 10.1007/s00280-015-2843-3. Epub 2015 Aug 11.

PMID:
26259641
17.

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.

Kato M, Shukuya T, Takahashi F, Mori K, Suina K, Asao T, Kanemaru R, Honma Y, Muraki K, Sugano K, Shibayama R, Koyama R, Shimada N, Takahashi K.

BMC Cancer. 2014 Jul 10;14:508. doi: 10.1186/1471-2407-14-508.

18.

Acrolein, a highly toxic aldehyde generated under oxidative stress in vivo, aggravates the mouse liver damage after acetaminophen overdose.

Arai T, Koyama R, Yuasa M, Kitamura D, Mizuta R.

Biomed Res. 2014;35(6):389-95. doi: 10.2220/biomedres.35.389.

19.

Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer.

Muraki K, Koyama R, Honma Y, Yagishita S, Shukuya T, Ohashi R, Takahashi F, Kido K, Iwakami S, Sasaki S, Iwase A, Takahashi K.

J Thorac Dis. 2012 Dec;4(6):562-8. doi: 10.3978/j.issn.2072-1439.2012.10.16.

20.

[Efficacy of erlotinib after gefitinib administration in patients with non-small cell lung cancer].

Murakami A, Ohashi R, Minakata K, Koyama R, Muraki K, Shukuya T, Namba Y, Ko R, Yagishita S, Katsura Y, Takahashi F, Sakuraba S, Takahashi K.

Gan To Kagaku Ryoho. 2012 Sep;39(9):1357-61. Japanese.

PMID:
22996769

Supplemental Content

Loading ...
Support Center